Venture funds

#BioIndustry Association #Biotech #Financing #Investment #Venture funds

Q3 UK biotech VC heads for record year thanks to megadeals

UK biotech venture capital investment reached £270 million ($359 million), up 44% from £187 million ($248 million) in Q3 2025, according to new figures from the BioIndustry Association (BIA), as the sector heads for its best year since 2021.  The latest upswing comes as overall UK venture capital investment declines… Read More

#Business & Investment #Editor's Choice #News

#Investment #Life sciences #Venture funds

Sofinnova Partners expands expertise with new partner  

Venture capital firm Sofinnova Partners has appointed a deep pharma and drug development expert as Partner, the company has announced.  David Evans is a physician-scientist with deep pharma and drug development expertise. He joins from the Roche Venture Fund, where he previously served as Senior Investment Director. There, he built a… Read More

#News

#Biotechnology #Europe #Funding #Venture funds

European biotech venture builder Kurma closes €215m fund

Kurma Partners, a European healthcare venture capital firm, has announced the final closing of Biofund IV at €215 million.   The new fund will support the discovery and development of disruptive therapeutic solutions for severe or incurable diseases.   Building on the €160 million Biofund III, this successful fundraise has increased the… Read More

#Business & Investment #News

#Biotech #Europe #Investment #Start-ups #Venture funds

European biotech venture funds raise over €1.1 billion

Two European biotech venture funds have raised over €1.1 billion in capital in the last week.  Sofinnova Partners announced the close of Sofinnova Capital XI at €650 million, while Medicxi closed its Medicxi V fund at €500 million.  Sofinnova Capital XI attracted strong support from a global base of blue-chip… Read More

#Business & Investment #Editor's Choice #News #Start-up Zone